ArticleMethodsX2026
Optimization of CD34⁺ hematopoietic stem and progenitor cell isolation from human peripheral blood and evaluation of short-term culture conditions.
Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The recovery of viable, high-purity CD34⁺ cells from peripheral blood remains challenging for research applications. This study describes an optimisation process beginning with traditional Ficoll-based density gradient centrifugation and progressing to SepMate™ technology, combined with different magnetic separation systems and culture conditions, to establish an improved protocol for CD34⁺ cell isolation and subsequent culture for further research use. Early trials focused on cell concentration and seeding densities in stationary culture. Comparison of different density-gradient approaches indicated that the multiple centrifugation steps and prolonged processing times associated with Ficoll-based enrichment reduced CD34⁺ cell purity and viability compared with enrichment using SepMate™ tubes with Lymphoprep™. Column-based separation involving plunger-mediated elution was associated with reduced viability in the tested samples, although the effects of elution pressure could not be separated from processing duration or donor-specific variability. Despite multiple optimisation steps across enrichment, magnetic separation, and culture conditions, expansion of the cultured cells was not achieved. The methodological adjustments described here aim to improve the early handling of CD34⁺ cells from peripheral blood to provide a more reliable starting population for downstream culture studies and may facilitate the establishment of similar workflows in other laboratories.•The use of SepMate™ tubes for PBMC isolation improved cell viability and recovery compared with Ficoll-based density gradient centrifugation.•Different magnetic separation systems and culture conditions were evaluated to maintain cell viability and purity during culture.•Agitation during culture supported maintenance of viable cells; however, after seven days the total cell number remained low and did not exceed the initial cell input.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.